Meridian Medical Technologies, LLC, and the European Commission’s DG HERA Sign Agreement for 13 Countries From the EEA to Purchase Tecovirimat SIGA

Contributed by: Business Wire

Tags

Other Defense

Infectious Diseases

Contracts

Biotechnology

Other Health

Health

Pharmaceutical

General Health

Defense

Meridian Medical Technologies, LLC

More Like This

PR Newswire associated0

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe

Viromed Medical AG reaches milestone for cooperation with multinational corporation

PR Newswire associated0

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA

Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA

PR Newswire associated0

Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply